Dr Woojin Kim
Tabs
Publications related to this Person
Journal articles
Frieg B; Geraets JA; Strohäker T; Dienemann C; Mavroeidi P; Jung BC; Kim WS; Lee SJ; Xilouri M; Zweckstetter M; Schröder GF, 2022, 'Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein', Communications Biology, vol. 5, http://dx.doi.org/10.1038/s42003-022-03948-y
Fu YH; Zhou L; Li H; Hsiao JHT; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2022, 'Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease', Acta Neuropathologica, vol. 144, pp. 861 - 879, http://dx.doi.org/10.1007/s00401-022-02488-3
Katzeff JS; Lok HC; Bhatia S; Fu Y; Halliday GM; Kim WS, 2022, 'ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions', Frontiers in Molecular Neuroscience, vol. 15, http://dx.doi.org/10.3389/fnmol.2022.1043127
Galper J; Kim WS; Dzamko N, 2022, 'LRRK2 and Lipid Pathways: Implications for Parkinson's Disease.', Biomolecules, vol. 12, http://dx.doi.org/10.3390/biom12111597
Chedid J; Labrador-Garrido A; Zhong S; Gao J; Zhao Y; Perera G; Kim WS; Halliday GM; Dzamko N, 2022, 'A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology', Journal of Biological Chemistry, vol. 298, pp. 102260, http://dx.doi.org/10.1016/j.jbc.2022.102260
Galper J; Dean NJ; Pickford R; Lewis SJG; Halliday GM; Kim WS; Dzamko N, 2022, 'Lipid pathway dysfunction is prevalent in patients with Parkinson's disease', BRAIN, vol. 145, pp. 3472 - 3487, http://dx.doi.org/10.1093/brain/awac176
Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, vol. 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077
Fu Y; He Y; Phan K; Pickford R; Kim YB; Dzamko N; Halliday GM; Kim WS, 2022, 'Sex-specific lipid dysregulation in the Abca7 knockout mouse brain', Brain Communications, vol. 4, http://dx.doi.org/10.1093/braincomms/fcac120
Gregersen E; Betzer C; Kim WS; Kovacs G; Reimer L; Halliday GM; Thiel S; Jensen PH, 2021, 'Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity', Journal of Neuroinflammation, vol. 18, http://dx.doi.org/10.1186/s12974-021-02225-9
Katzeff JS; Kim WS, 2021, 'ATP-binding cassette transporters and neurodegenerative diseases', Essays in Biochemistry, vol. 65, pp. 1013 - 1024, http://dx.doi.org/10.1042/EBC20210012
He Y; Phan K; Bhatia S; Pickford R; Fu YH; Yang Y; Hodges JR; Piguet O; Halliday GM; Kim WS, 2021, 'Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia', Scientific Reports, vol. 11, http://dx.doi.org/10.1038/s41598-021-00870-x
Bright F; Katzeff JS; Hodges JR; Piguet O; Kril JJ; Halliday GM; Kim WS, 2021, 'Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease', Frontiers in Immunology, vol. 12, pp. 736260, http://dx.doi.org/10.3389/fimmu.2021.736260
Youssef P; Kim WS; Halliday GM; Lewis SJG; Dzamko N, 2021, 'Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson's Disease Patients', Journal of Parkinson's Disease, vol. 11, pp. 1761 - 1772, http://dx.doi.org/10.3233/jpd-212694
Phan K; He Y; Fu Y; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.', Commun Med (Lond), vol. 1, http://dx.doi.org/10.1038/s43856-021-00060-w
Phan K; He Y; Pickford R; Bhatia S; Katzeff JS; Hodges JR; Piguet O; Halliday GM; Kim WS, 2020, 'Uncovering pathophysiological changes in frontotemporal dementia using serum lipids', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-60457-w
Katzeff JS; Bright F; Lo K; Kril JJ; Connolly A; Crossett B; Ittner LM; Kassiou M; Loy CT; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2020, 'Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-70687-7
Newman M; Nik HM; Sutherland GT; Hin N; Kim WS; Halliday GM; Jayadev S; Smith C; Laird AS; Lucas CW; Kittipassorn T; Peet DJ; Lardelli M, 2020, 'Accelerated loss of hypoxia response in zebrafish with familial Alzheimer's disease-like mutation of presenilin 1', Human Molecular Genetics, vol. 29, pp. 2379 - 2394, http://dx.doi.org/10.1093/hmg/ddaa119
Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M, 2019, 'Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts', Nature Communications, vol. 10, http://dx.doi.org/10.1038/s41467-019-13564-w
Hsiao JHT; Purushothuman S; Jensen PH; Halliday GM; Kim WS, 2019, 'Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain', Frontiers in Neuroscience, vol. 13, pp. 1187, http://dx.doi.org/10.3389/fnins.2019.01187
Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu YH; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ, 2019, 'Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone', Brain, vol. 142, pp. 2845 - 2859, http://dx.doi.org/10.1093/brain/awz205
Katzeff JS; Phan K; Purushothuman S; Halliday GM; Kim WS, 2019, 'Cross-examining candidate genes implicated in multiple system atrophy', Acta neuropathologica communications, vol. 7, pp. 117, http://dx.doi.org/10.1186/s40478-019-0769-4
Forrest SL; Crockford DR; Sizemova A; Mccann H; Shepherd CE; Mcgeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; Mcginley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM, 2019, 'Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration', Neurology, vol. 92, pp. e2472 - e2482, http://dx.doi.org/10.1212/WNL.0000000000007530
Ahmed RM; Phan K; Highton-Williamson E; Strikwerda-Brown C; Caga J; Ramsey E; Zoing M; Devenney E; Kim WS; Hodges JR; Piguet O; Halliday GM; Kiernan MC, 2019, 'Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia', Annals of Clinical and Translational Neurology, vol. 6, pp. 486 - 495, http://dx.doi.org/10.1002/acn3.721
Newman M; Moussavi Nik H; Sutherland G; Kim W; Halliday G; Jayadev S; Smith C; Kittipassorn T; Peet D; Lardelli M, 2019, 'Accelerated loss of hypoxia response and biased allele expression in zebrafish with Alzheimer's disease-like mutations', , http://dx.doi.org/10.1101/526277
Bhatia S; Kim WS; Shepherd CE; Halliday GM, 2019, 'Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia', Journal of Molecular Neuroscience, vol. 67, pp. 125 - 132, http://dx.doi.org/10.1007/s12031-018-1217-9
Atashrazm F; Hammond D; Perera G; Dobson-Stone C; Mueller N; Pickford R; Kim WS; Kwok JB; Lewis SJG; Halliday GM; Dzamko N, 2018, 'Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease', Scientific Reports, vol. 8, http://dx.doi.org/10.1038/s41598-018-33921-x
Kim WS; He Y; Phan K; Ahmed RM; Rye KA; Piguet O; Hodges JR; Halliday GM, 2018, 'Altered high density lipoprotein composition in behavioral variant frontotemporal dementia', Frontiers in Neuroscience, vol. 12, pp. 847, http://dx.doi.org/10.3389/fnins.2018.00847
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Gotz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies (vol 141, pg 521, 2018)', BRAIN, vol. 141, http://dx.doi.org/10.1093/brain/awy012
Rusznák Z; Sengul G; Paxinos G; Kim WS; Fu YH, 2018, 'Odor enrichment increases hippocampal neuron numbers in mouse', Experimental Neurobiology, vol. 27, pp. 94 - 102, http://dx.doi.org/10.5607/en.2018.27.2.94
Kim WS; Jary E; Pickford R; He Y; Ahmed RM; Piguet O; Hodges JR; Halliday GM, 2018, 'Lipidomics analysis of behavioral variant frontotemporal dementia: A scope for biomarker development', Frontiers in Neurology, vol. 9, http://dx.doi.org/10.3389/fneur.2018.00104
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies', Brain, vol. 141, pp. 521 - 534, http://dx.doi.org/10.1093/brain/awx328
Walsh RR; Krismer F; Galpern WR; Wenning GK; Low PA; Halliday G; Koroshetz WJ; Holton J; Quinn NP; Rascol O; Shaw LM; Eidelberg D; Bower P; Cummings JL; Abler V; Biedenharn J; Bitan G; Brooks DJ; Brundin P; Fernandez H; Fortier P; Freeman R; Gasser T; Hewitt A; Höglinger GU; Huentelman MJ; Jensen PH; Jeromin A; Kang UJ; Kaufmann H; Kellerman L; Khurana V; Klockgether T; Kim WS; Langer C; Lewitt P; Masliah E; Meissner W; Melki R; Ostrowitzki S; Piantadosi S; Poewe W; Robertson D; Roemer C; Schenk D; Schlossmacher M; Schmahmann JD; Seppi K; Shih L; Siderowf A; Stebbins GT; Stefanova N; Tsuji S; Sutton S; Zhang J, 2018, 'Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting', Neurology, vol. 90, pp. 74 - 82, http://dx.doi.org/10.1212/WNL.0000000000004798
Kim WS; Fu Y; Dobson-Stone C; Hsiao JHT; Shang K; Hallupp M; Schofield PR; Garner B; Karl T; Kwok JBJ, 2018, 'Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory', Journal of Alzheimer's Disease, vol. 62, pp. 1777 - 1787, http://dx.doi.org/10.3233/JAD-171001
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM, 2017, 'Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis', Acta neuropathologica communications, vol. 5, pp. 76, http://dx.doi.org/10.1186/s40478-017-0480-2
Hsiao JHT; Halliday GM; Kim WS, 2017, 'α-Synuclein regulates neuronal cholesterol efflux', Molecules, vol. 22, http://dx.doi.org/10.3390/molecules22101769
Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR, 2017, 'Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia', Journal of Alzheimer's Disease, vol. 58, pp. 163 - 170, http://dx.doi.org/10.3233/JAD-161272
Ahmed RM; Highton-Williamson E; Caga J; Thornton N; Ramsey E; Zoing M; Kim WS; Halliday GM; Piguet O; Hodges JR; Farooqi IS; Kiernan MC, 2017, 'Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition', Journal of Alzheimer's Disease, vol. 61, pp. 773 - 783, http://dx.doi.org/10.3233/JAD-170660
Bhatia S; Fu Y; Hsiao J-HT; Halliday GM; Kim WS, 2017, 'Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels', JOURNAL OF ALZHEIMERS DISEASE REPORTS, vol. 1, pp. 237 - 247, http://dx.doi.org/10.3233/ADR-170029
Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2016, 'ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain', Journal of Alzheimer's Disease, vol. 54, pp. 569 - 584, http://dx.doi.org/10.3233/JAD-160456
Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2016, 'Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0157924
Rusznák Z; Henskens W; Schofield E; Kim WS; Fu YH, 2016, 'Adult neurogenesis and gliogenesis: Possible mechanisms for neurorestoration', Experimental Neurobiology, vol. 25, pp. 103 - 112, http://dx.doi.org/10.5607/en.2016.25.3.103
Mills JD; Ward M; Kim WS; Halliday GM; Janitz M, 2016, 'Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome', Neuroscience, vol. 322, pp. 234 - 250, http://dx.doi.org/10.1016/j.neuroscience.2016.02.042
Bleasel JM; Halliday GM; Kim WS, 2016, 'Animal modeling an oligodendrogliopathy--multiple system atrophy', Acta neuropathologica communications, vol. 4, pp. 12, http://dx.doi.org/10.1186/s40478-016-0279-6
Rusznák Z; Kim WS; Hsiao JHT; Halliday GM; Paxinos G; Fu YH, 2015, 'Early in vivo effects of the human mutant amyloid-β protein precursor (hAβPPSwInd) on the mouse olfactory bulb', Journal of Alzheimer's Disease, vol. 49, pp. 443 - 457, http://dx.doi.org/10.3233/JAD-150368
Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2015, 'Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease', Current Alzheimer Research, vol. 12, pp. 745 - 751, http://dx.doi.org/10.2174/1567205012666150710110756
Mills JD; Chen J; Kim WS; Waters PD; Prabowo AS; Aronica E; Halliday GM; Janitz M, 2015, 'Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter', Neurogenetics, vol. 16, pp. 201 - 213, http://dx.doi.org/10.1007/s10048-015-0445-1
Mills JD; Kim WS; Halliday GM; Janitz M, 2015, 'Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy', Neurogenetics, vol. 16, pp. 107 - 122, http://dx.doi.org/10.1007/s10048-014-0430-0
Mills JD; Kavanagh T; Kim WS; Chen BJ; Waters PD; Halliday GM; Janitz M, 2015, 'High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation', Molecular brain, vol. 8, pp. 2, http://dx.doi.org/10.1186/s13041-014-0091-9
Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2015, 'ABCA5 Regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology', Journal of Alzheimer's Disease, vol. 43, pp. 857 - 869, http://dx.doi.org/10.3233/JAD-141320
Bleasel JM; Wong JH; Halliday GM; Kim WS, 2014, 'Lipid dysfunction and pathogenesis of multiple system atrophy', Acta Neuropathologica Communications, vol. 2, http://dx.doi.org/10.1186/2051-5960-2-15
Don AS; Hsiao JHT; Bleasel JM; Couttas TA; Halliday GM; Kim WS, 2014, 'Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy', Acta Neuropathologica Communications, vol. 2, http://dx.doi.org/10.1186/s40478-014-0150-6
Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM, 2014, 'Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease', Brain, vol. 137, pp. 834 - 848, http://dx.doi.org/10.1093/brain/awt367
Fu YH; Rusznák Z; Kwok JBJ; Kim WS; Paxinos G, 2014, 'Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse', Journal of Alzheimer's Disease, vol. 41, pp. 1177 - 1192, http://dx.doi.org/10.3233/JAD-132717
Kim WS; Kagedal K; Halliday GM, 2014, 'Alpha-synuclein biology in Lewy body diseases', Alzheimer's Research and Therapy, vol. 6, http://dx.doi.org/10.1186/s13195-014-0073-2
Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JBJ, 2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, vol. 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784
Wong JH; Halliday GM; Kim WS, 2014, 'Exploring myelin dysfunction in multiple system atrophy.', Exp Neurobiol, vol. 23, pp. 337 - 344, http://dx.doi.org/10.5607/en.2014.23.4.337
Coupland K; Kim WS; Halliday G; Dobson‐Stone C; Kwok JBJ, 2014, 'P1‐039: MAPT METHYLATION IN ALZHEIMER'S DISEASE', Alzheimer's & Dementia, vol. 10, pp. P317 - P318, http://dx.doi.org/10.1016/j.jalz.2014.05.274
Bleasel JM; Hsiao JHT; Halliday GM; Kim WS, 2013, 'Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins', Journal of Parkinson's Disease, vol. 3, pp. 331 - 339, http://dx.doi.org/10.3233/JPD-130203
Mills JD; Kavanagh T; Kim WS; Chen BJ; Kawahara Y; Halliday GM; Janitz M, 2013, 'Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0078480
Dang TNT; Dobson-Stone C; Glaros EN; Kim WS; Hallupp M; Bartley L; Piguet O; Hodges JR; Halliday GM; Double KL; Schofield PR; Crouch PJ; Kwok JBJ, 2013, 'Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model', DMM Disease Models and Mechanisms, vol. 6, pp. 1198 - 1204, http://dx.doi.org/10.1242/dmm.011460
Hsiao JHT; Fu YH; Hill AF; Halliday GM; Kim WS, 2013, 'Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0074016
Kim WS; Li H; Ruberu K; Chan S; Low JK; Low JK; Cheng D; Karl T; Garner B; Elliott D, 2013, 'Deletion of Abca7 increases cerebral amyloid-â accumulation in the J20 mouse model of Alzheimer's disease', Journal of Neuroscience, vol. 33, pp. 4387 - 4394, http://dx.doi.org/10.1523/JNEUROSCI.4165-12.2013
Kim WS; Hsiao JT; Bhatia S; Glaros E; Don AS; Tsuruoka S; Shannon Weickert CS; Halliday GM, 2013, 'ABCA8 stimulates sphingomyelin production in oligodendrocytes', Biochemical Journal, vol. 452, pp. 401 - 410, http://dx.doi.org/10.1042/BJ20121764
Bhatia S; Knoch B; Wong J; Kim WS; Else PL; Oakley AJ; Garner B, 2012, 'Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: Implications for lipid antioxidant activity and Alzheimer's disease', Biochemical Journal, vol. 442, pp. 713 - 721, http://dx.doi.org/10.1042/BJ20111166
Kavanagh T; Mills JD; Kim WS; Halliday GM; Janitz M, 2012, 'Pathway analysis of the human brain transcriptome in disease', Journal of Molecular Neuroscience, vol. Published online, pp. 28 - 36, http://dx.doi.org/10.1007/s12031-012-9940-0
Logge W; Cheng DK; Chesworth R; Bhatia S; Garner B; Kim WS; Karl T, 2012, 'Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases', PLoS ONE, vol. 7, pp. Article numbere45959, http://dx.doi.org/10.1371/journal.pone.0045959
Karl T; Bhatia S; Cheng D; Kim WS; Garner B, 2012, 'Cognitive phenotyping of amyloid precursor protein transgenic J20 mice', Behavioural Brain Research, vol. 228, pp. 392 - 397, http://dx.doi.org/10.1016/j.bbr.2011.12.021
Elliott DA; Kim WS; Gorissen SV; Halliday GM; Kwok J, 2012, 'Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease', Movement Disorders, vol. 27, pp. 1004 - 1011, http://dx.doi.org/10.1002/mds.25005
Kim WS; Halliday , 2012, 'Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression', Journal of Parkinson's Disease, vol. 2, pp. 41 - 46, http://dx.doi.org/10.3233/JPD-2012-11059
Elliott DA; Tsoi K; Holinkova S; Chan LL; Kim WS; Halliday GM; Rye K; Garner B, 2011, 'Isoform-specific proteolysis of apolipoprotein-E in the brain', Neurobiology of Aging, vol. 32, pp. 257 - 271, http://dx.doi.org/10.1016/j.neurobiolaging.2009.02.006
Cheng D; Jenner AM; Shui G; Cheong WF; Mitchell T; Nealon J; Kim WS; McCann H; Wenk M; Halliday ; Garner B, 2011, 'Lipid pathway alterations in parkinson's disease primary visual cortex', PLoS One, vol. 6, pp. e17299, http://dx.doi.org/10.1371/journal.pone.0017299
Kim WS; Hill A; Fitzgerald M; Freeman MW; Evin G; Garner B, 2011, 'Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-beta production independent of cholesterol efflux activity', Journal of Alzheimer's Disease, vol. 27, pp. 441 - 452, http://dx.doi.org/10.3233/JAD-2011-110521
Kagedal K; Kim WS; Appelqvist A; Chan LL; Cheng D; Agholme L; Barnham K; Mccann H; Halliday GM; Garner B, 2010, 'Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, vol. 1801, pp. 831 - 838, http://dx.doi.org/10.1016/j.bbalip.2010.05.005
Li H; Kim WS; Guillemin GJ; Hill AF; Evin G; Garner B, 2010, 'Modulation of amyloid precursor protein processing by synthetic ceramide analogues', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, vol. 1801, pp. 887 - 895, http://dx.doi.org/10.1016/j.bbalip.2010.05.012
Glaros E; Kim WS; Garner B, 2010, 'Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition', Clinical Science, vol. 118, pp. 727 - 736, http://dx.doi.org/10.1042/CS20090452
Kim WS; Bhatia S; Elliott DA; Agholme L; Kagedal K; Mccann H; Halliday GM; Barnham K; Garner B, 2010, 'Increased ATP-binding cassette trabsporter A1 expression in Alzheimer's disease hippocampal neurons', Journal of Alzheimer's Disease, vol. 21, pp. 193 - 205, http://dx.doi.org/10.3233/JAD-2010-100324
Kågedal K; Kim W; Appelqvist H; Chan S; Cheng D; Hellström L; Barnham K; McCann H; Halliday G; Garner B, 2010, 'P4‐153: Increased Expression of the Lysosomal Cholesterol Transporter NPC1 in Alzheimer's Disease', Alzheimer's & Dementia, vol. 6, pp. e68 - e69, http://dx.doi.org/10.1016/j.jalz.2010.08.212
Scott Kim W; Chan SL; Hill AF; Guillemin GJ; Garner B, 2009, 'Impact of 27-hydroxycholesterol on amyloid-β peptide production and ATP-binding cassette transporter expression in primary human neurons', Journal of Alzheimer's Disease, vol. 16, pp. 121 - 131, http://dx.doi.org/10.3233/JAD-2009-0944
Kim WS; Chan LL; Hill AF; Guillemin GJ; Garner B, 2009, 'Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons', Journal of Alzheimer's Disease, vol. 16, pp. 121 - 131, http://dx.doi.org/10.3233/JAD-2009-0944
Kim WS; Wong J; Shannon-Weickert C; Webster MJ; Bahn S; Garner B, 2009, 'Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex', Journal of Neurochemistry, vol. Volume 109, pp. 1053 - 1066, http://dx.doi.org/10.1111/j.1471-4159.2009.06031.x
Chan SLL; Kim WS; Hill AF; Garner B, 2009, 'P1‐005: ATP‐binding cassette transporter A7 inhibits amyloid‐beta production in vitro', Alzheimer's & Dementia, vol. 5, pp. P173 - P173, http://dx.doi.org/10.1016/j.jalz.2009.04.008
Glaros E; Kim W; Garner B, 2009, 'Abstract: P405 ANTI-ATHEROGENIC MECHANISMS OF SPHINGOLIPID SYNTHESIS INHIBITOR MYRIOCIN IN HEPATOCYTES', Atherosclerosis Supplements, vol. 10, pp. e715 - e715, http://dx.doi.org/10.1016/s1567-5688(09)70700-7
Chan LL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye K; Garner B, 2008, 'ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro', Journal of Neurochemistry, vol. 106, pp. 793 - 804, http://dx.doi.org/10.1111/j.1471-4159.2008.05433.x
Cheng D; Kim WS; Garner B, 2008, 'Regulation of alpha-synuclein expression by liver X receptor ligands in vitro', Neuroreport, vol. 19, pp. 1685 - 1689, http://dx.doi.org/10.1097/WNR.0b013e32831578b2
Glaros EN; Kim WS; Rye K; Shayman J; Garner B, 2008, 'Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice', Journal of Lipid Research, vol. 49, pp. 1677 - 1681, http://dx.doi.org/10.1194/jlr.E800005-JLR200
Glaros EN; Kim WS; Quinn CM; Jessup W; Rye K; Garner B, 2008, 'Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice', Journal of Lipid Research, vol. 49, pp. 324 - 331, http://dx.doi.org/10.1194/jlr.M700261-JLR200
Kim WS; Elliott DA; Kockx M; Kritharides L; Rye K; Jans D; Garner B, 2008, 'Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches', Biochemical Journal, vol. 409, pp. 701 - 709, http://dx.doi.org/10.1042/BJ20071261
Kim WS; Shannon-Weickert C; Garner B, 2008, 'Role of ATP-binding cassette transporters in brain lipid transport and neurological disease', Journal of Neurochemistry, vol. 104, pp. 1145 - 1166, http://dx.doi.org/10.1111/j.1471-4159.2007.05099
Elliott DA; Kim WS; Jans D; Garner B, 2008, 'Macrophage apolipoprotein-E knockdown modulates caspase-3 activation without altering sensitivity to apoptosis', Biochimica et Biophysica ACTA - General Subjects, vol. 1780, pp. 145 - 153, http://dx.doi.org/10.1016/j.bbagen.2007.10.021
Elliott DA; Kim WS; Halliday GM; Garner B, 2008, 'P3-294: Post-translational modifications of apolipoprotein-e in the human brain', Alzheimer's & Dementia, vol. 4, pp. T608 - T608, http://dx.doi.org/10.1016/j.jalz.2008.05.1862
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye K; Stocker R; Jessup W; Garner B, 2007, 'Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration', Biochemical Pharmacology, vol. 73, pp. 1340 - 1346, http://dx.doi.org/10.1016/j.bcp.2006.12.023
Kim WS; Rahmanto A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation', The Journal of Biological Chemistry, vol. 282, pp. 2851 - 2861, http://dx.doi.org/10.1074/jbc.M607831200
Elliott DA; Kim WS; Jans D; Garner B, 2007, 'Apoptosis induces neuronal apolipoprotein-E synthesis and localization in apoptotic bodies', Neuroscience Letters, vol. 416, pp. 206 - 210, http://dx.doi.org/10.1016/j.neulet.2007.02.014
Kim WS; Guillemin GJ; Glaros EN; Garner B, 2006, 'Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells', Neuroreport, vol. 17, pp. 891 - 896, http://dx.doi.org/10.1097/01.wnr.0000221833.41340.cd
Kim WS; Chalfant CE; Garner B, 2006, 'Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosis', Current Vascular Pharmacology, vol. 4, pp. 151 - 154, http://dx.doi.org/10.2174/157016106776359844
Kim WS; Fitzgerald ML; Kang K; Okuhira KI; Bell SA; Manning JJ; Koehn SL; Lu N; Moore KJ; Freeman MW, 2005, 'Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels', Journal of Biological Chemistry, vol. 280, pp. 3989 - 3995, http://dx.doi.org/10.1074/jbc.M412602200
Liu C; Su P; Khunajakr N; Deng YM; Sumual S; Kim WS; Tandianus JE; Dunn NW, 2005, 'Development of food-grade cloning and expression vectors for Lactococcus lactis', Journal of Applied Microbiology, vol. 98, pp. 127 - 135, http://dx.doi.org/10.1111/j.1365-2672.2004.02441.x
Quenee P; LePage E; Kim WS; Vergnaud G; Gruss A, 2005, 'Minisatellite polymorphism as a tool to distinguish closely related Lactococcus lactis strains', FEMS Microbiology Letters, vol. 248, pp. 101 - 109, http://dx.doi.org/10.1016/j.femsle.2005.05.026
Kim WS; Ordija CM; Freeman MW, 2003, 'Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A', Biochemical and Biophysical Research Communications, vol. 310, pp. 542 - 549, http://dx.doi.org/10.1016/j.bbrc.2003.09.049
Cardona TD; Driscoll RH; Paterson JL; Srzednicki GS; Kim WS, 2002, 'Optimizing conditions for heat pump dehydration of lactic acid bacteria', Drying Technology, vol. 20, pp. 1611 - 1632, http://dx.doi.org/10.1081/DRT-120014054
Ren J; Park JH; Dunn NW; Kim WS, 2001, 'Sequence and stress-response analyses of the DNA mismatch repair gene hexA in Lactococcus lactis', Current Microbiology, vol. 43, pp. 232 - 237, http://dx.doi.org/10.1007/s002840010293
Kim WS; Ren J; Dunn NW, 2001, 'Assessment of the tolerance of Lactococcus lactis cells at elevated temperatures', Biotechnology Letters, vol. 23, pp. 1141 - 1145, http://dx.doi.org/10.1023/A:1010524303261
Kim WS; Park J; Dunn NW; Tandianus JE; Perl L, 2001, 'Assessment of Stress Response of the Probiotic Lactobacillus acidophilus', Current Microbiology, vol. 43, pp. 346 - 350, http://dx.doi.org/10.1007/s002840010314
Kim WS; Park JH; Ren J; Su P; Dunn NW, 2001, 'Survival Response and Rearrangement of Plasmid DNA of Lactococcus lactis during Long-Term Starvation', Applied Microbiology and Biotechnology, vol. 67, pp. 4594 - 4602, http://dx.doi.org/10.1128/AEM.67.10.4594-4602.2001
Dunn NW; Dai G; Su P; Kim WS, 2001, 'Molecular Characterization of a New Abortive Infection System (AbiU) from Lactococcus lactis LL51-1', Applied Microbiology and Biotechnology, vol. 67, pp. 5225 - 5232
Kim WS; Ren J; Dunn NW, 1999, 'Differentiation of Lactococcus lactis subspecies lactis and subspecies cremoris strains by their adaptive response to stresses', FEMS Microbiology Letters, vol. 171, pp. 57 - 65, http://dx.doi.org/10.1016/S0378-1097(98)00578-3
Duan KM; Dunn NW; Kim WS, 1999, 'Rapid plasmid DNA isolation from Lactococcus lactis using overnight cultures', Biotechnology Techniques, vol. 13, pp. 519 - 521, http://dx.doi.org/10.1023/A:1008963715449
Kim WS; Hall R; Dunn NW, 1998, 'Improving nisin production by increasing nisin immunity/resistance genes in the producer organism Lactococcus lactis.', Applied Microbiology and Biotechnology, vol. 50, pp. 429 - 433, http://dx.doi.org/10.1007/s002530051316
Kim WS; Khunajakr N; Dunn NW, 1998, 'Effect of cold shock on protein synthesis and on cryotolerance of cells frozen for long periods in Lactococcus lactis', Cryobiology, vol. 37, pp. 86 - 91, http://dx.doi.org/10.1006/cryo.1998.2104
Kim WS; Khunajakr N; Ren J; Dunn NW, 1998, 'Conservation of the major cold shock protein in Lactic acid bacteria', Current Microbiology, vol. 37, pp. 333 - 336, http://dx.doi.org/10.1007/s002849900387
Kim WS; Hall R; Dunn NW, 1997, 'HOST SPECIFICITY OF NISIN PRODUCTION BY LACTOCOCCUS LACTIS', Biotechnology Letters, vol. 19, pp. 1235 - 1238, http://dx.doi.org/10.1023/A:1018450223732
Kim WS; Hall R; Dunn NW, 1997, 'THE EFFECT OF NISIN CONCENTRATION AND NUTRIENT DEPLETION ON NISIN PRODUCTION OF LACTOCOCCUS LACTIS', Applied Microbiology and Biotechnology, vol. 48, pp. 449 - 453, http://dx.doi.org/10.1007/s002530051078
Kim WS; Dunn NW, 1997, 'STABILIZATION OF THE LACTOCOCCUS LACTIS NISIN PRODUCTION TRANSPOSON AS A PLASMID', FEMS Microbiology Letters, vol. 146, pp. 285 - 289, http://dx.doi.org/10.1016/S0378-1097(96)00489-2
Kim WS, 1997, 'NISIN PRODUCTION BY LACTOCOCCUS LACTIS USING TWO-PHASE BATCH CULTURE', Letters in Applied Microbiology, vol. 25, pp. 169 - 171, http://dx.doi.org/10.1046/j.1472-765X.1997.00195.x
Kim WS; Dunn NW, 1997, 'IDENTIFICATION OF A COLD SHOCK GENE IN LACTIC ACID BACTERIA AND THE EFFECT OF COLD SHOCK ON CRYOTOLERANCE', Current Microbiology, vol. 35, pp. 59 - 63, http://dx.doi.org/10.1007/s002849900212
Kim WS; Smith A; Trent RJ; Kim WS, 1996, 'Isolation of a eDNA-Derived Expressed-Sequence-Tag Clone on Chromosome 15', Disease Markers, vol. 12, pp. 275 - 278, http://dx.doi.org/10.1155/1996/450297
Kim WS, 1994, 'A simple and quick method of isolating DNA fragments from agarose gel suitable for molecular procedures', Methods in Molecular and Cellular Biology, vol. 5, pp. 242 - 244
Conference Papers
van Langenhove T; Piguet O; Burrell J; Leyton C; Foxe D; Abela M; Bartley L; Kim W; Jary E; Huang Y; Dobson-Stone C; Kwok J; Halliday G; Hodges JR, 2017, 'Predicting development of amyotrophic lateral sclerosis in frontotemporal dementia', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NETHERLANDS, Amsterdam, pp. 104 - 104, presented at 3rd Congress of the European-Academy-of-Neurology, NETHERLANDS, Amsterdam, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000405530100170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Wong J; Shepherd CE; Kim WS; Garner B; Weickert CS, 2010, 'IS THERE EVIDENCE FOR OXIDATIVE STRESS IN THE PREFRONTAL CORTEX OF PATIENTS WITH SCHIZOPHRENIA?', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, INFORMA HEALTHCARE, pp. A19 - A19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kim WS; Hill AF; Garner B, 2007, 'Impact of human neuronal ABC transporters on cholesterol efflux and amyloid-beta production', in Hanin I; Windisch M; Poewe W; Fisher A (eds.), NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007, MEDIMOND S R L, Salzburg, AUSTRIA, pp. 43 - 47, presented at 8th International Conference on Alzheimer's and Parkinson's Diseases, Salzburg, AUSTRIA, 14 March 2007 - 18 March 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257460200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Abstracts
Kwok J; Coupland K; Mellick G; Mather K; Thalamuthu A; Armstrong N; Sachdev P; Brodaty H; Wright M; Ames D; Allen M; Ertekin-Taner N; McRae A; Bennett D; Jager PD; Kim W; Halliday G; Dobson-Stone C, 2015, 'Genome-wide association study identifies the SLC2A14 gene on chromosome 12P13 as a trans-acting locus for methylation of MAPT gene [Abstract MTU02-11]', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, Cairns, Australia, Vol. 134, pp. 113 - 114, presented at 25th Biennial Meeting of the International Society for Neurochemistry jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, Australia, 23 August 2015 - 27 August 2015, http://dx.doi.org/10.1111/jnc.13188
Preprints
Frieg B; Geraets JA; Strohäker T; Dienemann C; Mavroeidi P; Jung BC; Kim WS; Lee S-J; Xilouri M; Zweckstetter M; Schröder GF, 2021, α-Synuclein polymorphism determines oligodendroglial dysfunction, http://dx.doi.org/10.1101/2021.07.09.451731